Abbott Laboratories news

   Watch this stock
Showing stories 1 - 10 of about 115   

Articles published

ABT 47.09 -0.13 (-0.28%)
price chart
Abbott Laboratories Moves Up In Market Cap Rank, Passing Morgan Stanley
But comparing market capitalization (factoring in those share counts) creates a true �apples-to-apples� comparison of the value of two stocks.
Abbott Laboratories' Management Presents at Cowen & Company 35th Annual ...
My pleasure to introduce the Abbott team here today, we have Brian Yoor, Vice President of Investor Relations, and we also will be having the head of international nutrition head Scott White, heading up international nutrition, he will be available for ...
Zoetis Inc Acquires Abbott Laboratories Animal-Health Assets
Zoetis Inc (NYSE:ZTS) is already the largest company in the animal-health industry, with a hefty $4.6 billion sales in 2013. The acquisition of Abbott's assets will add various products to its animal-products portfolio, including veterinarians ...
Zoetis completes $255 million acquisition of Abbott Animal Health assets
How Acquisition Of Animal Health Segment Of Abbott Will Profit Zoetis Inc ...
Mylan closes $5.3B tax-lowering deal with Abbott Labs
Generic drugmaker Mylan NV officially moved its corporate address to the Netherlands on Friday when it completed its acquisition of an overseas business unit from Abbott Laboratories for $5.3 billion in stock. The controversial move allows Mylan to ...
Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets ...  PR Newswire (press release)
Mylan inversion deal completed  Pittsburgh Business Times
ABT Stock � 3 Reasons to Buy and Hold This Dividend Aristocrat
Abbott Laboratories has increased dividend payouts for an impressive 42 consecutive years, making it a member of the S&P 500 Dividend Aristocrats Index.
John M. Capek Sells 34292 Shares of Abbott Laboratories Stock (ABT)  Dakota Financial News
Value Insights: Abbott Laboratories (NYSE:ABT)  Stock Markets Daily
Insider Selling: Abbott Laboratories SVP Jaime Contreras Sells 9209 Shares of ...
Abbott Laboratories logo Abbott Laboratories (NYSE:ABT) SVP Jaime Contreras sold 9,209 shares of the stock in a transaction that occurred on Monday, March 2nd.
Update: Abbott Laboratories Short Interest Drops by -5.8%  Stafford Daily
Share Price of Abbott Laboratories Drops by -0.23%  Ashburn Daily
Abbott Laboratories Upgraded by Zacks to "Neutral" (ABT)
Abbott Laboratories logo Zacks upgraded shares of Abbott Laboratories (NYSE:ABT) from an underperform rating to a neutral rating in a report issued on Thursday.
Abbott Laboratories Sets New 52-Week High at $47.88 (ABT)
Abbott Laboratories logo Abbott Laboratories (NYSE:ABT)'s share price reached a new 52-week high on Friday , AnalystRatingsNetwork reports.
Abbott vs. AbbVie: Look who's on top now
Abbott Laboratories is elbowing aside former corporate sibling AbbVie in the affections of Wall Street. Abbott's stock jumped as its outlook brightened last month, while new uncertainty at AbbVie sent the drugmaker's shares down.
Should You Buy AbbVie Inc. Stock on This Dip?  Motley Fool
Traders Sell Abbott Laboratories on Strength (ABT)
Abbott Laboratories logo Investors sold shares of Abbott Laboratories (NYSE:ABT) on strength during trading on Tuesday, Analyst Ratings Net reports.
Abbott Laboratories Stock Rating Reaffirmed by Jefferies Group (ABT)  Ticker Report
Abbott Laboratories Given Consensus Rating of �Hold� by Analysts (NYSE:ABT)  sleekmoney